肝硬化合并门静脉血栓治疗进展  

Advances in the treatment of liver cirrhosis with portal vein thrombosis

作　　者：李晓珂 杨新乐 王彤[1] 薛舒文 郭晓林[1] 季慧范[1] LI Xiaoke;YANG Xinle;WANG Tong;XUE Shuwen;GUO Xiaolin;JI Huifan(Department of Hepatobiliary and Pancreatic Medicine,The First Hospital of Jilin University,Changchun 130021,China)

机构地区：[1]吉林大学第一医院肝胆胰内科,长春130021

出　　处：《临床肝胆病杂志》2021年第7期1690-1693,共4页Journal of Clinical Hepatology

摘　　要：门静脉血栓(PVT)是肝硬化的常见并发症之一,由于肝硬化存在凝血功能障碍和出血风险,临床上对于肝硬化合并PVT的治疗存在诸多争议。PVT常用治疗方法包括抗凝、介入和溶栓,重点阐述了肝硬化合并PVT的治疗现状,以期为临床制订规范合理的治疗策略提供帮助。Portal vein thrombosis(PVT)is one of the most common complications of liver cirrhosis.Due to coagulation disorder and the risk of bleeding in liver cirrhosis,there are many controversies over the treatment of liver cirrhosis with PVT in clinical practice.Common therapies for PVT include anticoagulant therapy,intervention,and thrombolysis.This article elaborates on the current status of the treatment of liver cirrhosis with PVT,in order to provide help for the development of standard and reasonable clinical treatment strategies.

关 键 词：肝硬化 静脉血栓形成 治疗学 

分 类 号：R575.2[医药卫生—消化系统]